1. Accounting for the Drug Life Cycle and Future Drug Prices in Cost-Effectiveness Analysis

   • Martin Hoyle

   Leading Article 11 October 2012 Pages: 1 - 15

   

2. Effects of Reference Pricing in Pharmaceutical Markets

   • Matteo Maria Galizzi
   • Simone Ghislandi
   • Marisa Miraldo

   Review Article 11 October 2012 Pages: 17 - 33

   

3. Calibrating Models in Economic Evaluation

   • Tazio Vanni
   • Jonathan Karnon
   • Rosa Legood

   Review Article 11 October 2012 Pages: 35 - 49

   

4. Calibrating Models in Economic Evaluation

   • Jonathan Karnon
   • Tazio Vanni

   Original Research Article 11 October 2012 Pages: 51 - 62

   

5. Availability of and Access to Orphan Drugs

   • Carl Rudolf Blankart
   • Tom Stargardt
   • Jonas Schreyögg

   Original Research Article 11 October 2012 Pages: 63 - 82

   

6. Is There a Role for Pharmacoeconomics in Developing Countries?

   • Asrul Akmal Shafie
   • Mohamed Azmi Hassali

   Correspondence 11 October 2012 Pages: 83 - 84

7. The Authors’ Reply

   • Zaheer-Ud-Din Babar
   • Shane Scahill

   Correspondence 11 October 2012 Pages: 84 - 86